Market Cap
$132.58B
$95.34B
Country
United States
United States
Employees
88.00K
34.10K
Industry
🇺🇸 United States
🇺🇸 United States
Outstanding Shares
5.69B
2.04B
Comparison Verdict
About Pfizer and Bristol-Myers Squibb
Pfizer (PFE) and Bristol-Myers Squibb (BMY) are both prominent companies in their respective sectors. This comparison helps investors understand the key differences between these two stocks.
Key Takeaways
- Market Cap: Pfizer ($132.58B) vs Bristol-Myers Squibb ($95.34B)
- Valuation: Pfizer has a P/E ratio of $16.76 vs $17.50 for Bristol-Myers Squibb
- Dividend Yield: Pfizer offers 7.30% vs 5.20% from Bristol-Myers Squibb
- Assets: Pfizer has $213.40B in total assets compared to $92.43B for Bristol-Myers Squibb
- 1-Year Performance: Pfizer gained 0.23% vs gain of 0.47% for Bristol-Myers Squibb
- Outstanding Shares: Pfizer has 5.69B shares vs 2.04B for Bristol-Myers Squibb